Log in
Propedeutics · Blood System

Disseminated intravascular coagulation syndrome

Syndromum coagulationis intravascularis disseminatae

DIC syndrome is a severe symptom complex characterized by prolonged and uncontrolled hypercoagulation. The pathology has a paradoxical course: excessive microthrombus formation in the vascular bed inevitably leads to depletion of the clotting system and severe, life-threatening hemorrhaging.

Essence of the processTransition from massive thrombosis to profuse hemorrhage
Laboratory markersElevated levels of soluble fibrin monomer complexes (SFMC) and fibrin degradation products (FDP)
Basis of therapyEarly administration of 1–2 liters of fresh frozen plasma (FFP) per day
4 min readFor medical studentsUpdated 09/24/2026
Material prepared by WhiteCoat Pro editorial team based on platform study guidesReviewed by medical editor: Aulov A. A., general practitioner · 09/24/2026

Causes (Etiology)

It is important to understand that DIC syndrome is never an independent disease. It is a formidable complication that superimposes on the course of other critical conditions and drastically worsens the patient's prognosis.

The main etiological factors triggering this process include:

  • Shock states and severe mechanical trauma.
  • Generalized infections, primarily sepsis.
  • Extensive and traumatic surgical interventions.
  • Massive hemorrhages of any localization.
  • Obstetric pathology (severe pregnancy complications and pathological labor course).
  • Malignant neoplasms (oncological processes).
  • Systemic connective tissue diseases (a classic example is systemic lupus erythematosus).
  • Specific factors: marked hypoxia, as well as bites from certain species of venomous snakes.

Mechanism of development (Pathogenesis)

The pathogenesis of DIC syndrome is paradoxical and characterized by an extremely rapid, sometimes fulminant change of stages. It is based on the formation of multiple microthrombas that block microcirculation and cause functional insufficiency of internal organs, after which fibrinolysis is secondarily activated.

The dynamics of the process include the following stages:

  1. Triggering moment. Biologically active substances enter the systemic circulation. They aggressively damage the capillary endothelium and formed elements of the blood, primarily platelets and leukocytes.
  2. Hypercoagulation stage. An avalanche-like activation of the blood coagulation system occurs.
  3. Consumption coagulopathy stage. Due to massive thrombus formation, the body's reserves are depleted. A pronounced deficiency of clotting factors occurs, and the platelet count drops (thrombocytopenia). Hypocoagulation develops, and the fibrinolysis system is activated in parallel.
  4. Cyclicity. If the patient survives, the cycle may repeat: the hemorrhage is followed by a new wave of hypercoagulation and microthrombus formation.
Test your knowledgeTasks from the "Propaedeutics" course bank — get answers and explanations instantly.

Clinical presentation

The clinical manifestations of DIC syndrome consist of three main components: thrombosis, hemorrhages, and hemodynamic disorders. Symptoms are always superimposed on the picture of the primary disease.

  • Hemorrhagic syndrome. Manifests in extremely diverse ways: from small multiple hemorrhages (petechiae) to the formation of extensive confluent hematomas on the skin and visible mucous membranes. A characteristic iatrogenic sign is persistent bleeding from medical intervention sites (e.g., venipunctures and injections).
  • Organ disorders. The blockade of the microvasculature by thrombi leads to tissue oxygen starvation. Multiple organ dysfunction syndrome develops, which, along with profuse bleeding, poses the greatest danger to the patient's life.

Laboratory diagnostics and treatment

Diagnosis relies on laboratory data, which must be interpreted dynamically, as hypercoagulation can rapidly give way to hypocoagulation.

Changes in laboratory tests:

  • Complete blood count: anemia and thrombocytopenia are recorded.
  • Coagulogram: a deficiency of clotting factors (especially V, VIII, X, and XII) is detected. Blood clotting time is prolonged. Key markers of active thrombus formation and fibrinolysis are high levels of SFMC (soluble fibrin monomer complexes) and FDP (fibrin/fibrinogen degradation products).

Principles of therapy: The success of treatment directly depends on the speed of diagnosis.

  1. Replacement therapy. This is the basis of treatment. The fastest possible intravenous administration of fresh frozen plasma (FFP) is required to replenish the "consumed" clotting factors. The volume reaches 1–2 liters per day, divided into 2–3 doses.
  2. Drug support. Reopoliglyukin is used to improve blood rheological properties. Heparin can be used with great caution and under strict control to regulate coagulation processes.

Briefly: answers to topical questions

What specific types of obstetric pathology most frequently lead to the development of DIC syndrome?

The cited sources do not rank "most frequently"; the obstetric conditions in which DIC syndrome occurs are listed as:

  • severe forms of preeclampsia;
  • premature separation of a normally implanted or low-lying placenta;
  • amniotic fluid embolism;
  • dead fetus / intrauterine fetal death;
  • septic or hemorrhagic shock;
  • uterine rupture;
  • congenital hemostasis defects;
  • eclampsia;
  • HELLP syndrome.

For the acute form of DIC syndrome, the sources specifically indicate a massive single release of thromboplastic substances into the bloodstream: amniotic fluid in amniotic fluid embolism and tissue thromboplastins in premature separation of a normally implanted placenta or in dead fetus.

By what pathogenetic mechanism do venomous snake bites cause DIC syndrome?

In the sources, venomous snake bites are listed among the etiological factors of DIC syndrome, but the specific mechanism for bites alone is not described.

Within the framework of the cited pathogenesis of DIC syndrome, the mechanism can be formulated as follows:

  • biologically active substances appear in the blood, damaging the capillary endothelium and blood cells, predominantly platelets and leukocytes;
  • damage to blood cells is accompanied by the release of phospholipids, leading to the activation of intravascular coagulation;
  • the hypercoagulation stage develops with the formation of microthrombi;
  • subsequently, consumption coagulopathy, thrombocytopenia, hypocoagulation, and activation of fibrinolysis are possible.

Separately, sources indicate that the venoms of certain snakes can cause hemolysis, but do not directly link hemolysis to the mechanism of DIC syndrome development in bites.

How to memorize

To memorize the stages of pathogenesis, use the mnemonic: Trigger factor (endothelial damage), Amplification of clotting (hypercoagulation), Consumption of factors (consumption coagulopathy), Hemorrhage (hypocoagulation and fibrinolysis).

Class and exam questions

Why do severe hemorrhages occur in DIC syndrome if the core pathology is hypercoagulability?

Hemorrhages occur due to the mechanism of consumption coagulopathy. In the hypercoagulation stage, the body expends its entire reserve of platelets and clotting factors to form numerous microthrombi. When these resources are depleted, the blood loses its ability to clot, and fibrinolysis is activated, leading to hemorrhages.

Which coagulation factors are depleted first?

A deficiency of factors V, VIII, X, and XII is observed first. Their level can be assessed using an expanded coagulogram.

What is the main principle of treatment?

The main principle is early replacement therapy. It is necessary to administer fresh frozen plasma intravenously to the patient as quickly as possible (1–2 liters per day) to compensate for the deficiency of blood clotting factors.

Unclear on something? Ask the AIThe AI tutor has read the material on "Disseminated intravascular coagulation syndrome" and will explain it in simple terms.

What else to study on this topic

  • Mechanisms of endothelial damage in various shock states and sepsis.
  • The role of soluble fibrin monomer complexes (SFMC) in the diagnosis of thrombosis.
  • Pathophysiology of multiple organ dysfunction syndrome development during microcirculation blockade.
  • Functions of clotting factors V, VIII, X, and XII in the coagulation cascade.
  • Pharmacodynamics of Reopoliglucin and its effect on blood rheology.
  • Criteria for the safe use of heparin at different stages of DIC syndrome.

Master the entire topic in the "Propaedeutics" course

This is a summary. The course covers everything tested in classes and exams.

  • Comprehensive study guide on "Disseminated Intravascular Coagulation Syndrome" and 3,152 other pages on the subject
  • Assignments and quizzes after every topic — just like in a colloquium
  • AI tutor answers questions on the topic anytime
  • 113 video lessons on the subject

Other topics in the "Blood System" section

The entire "Blood System" section

Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.